Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.65 |
| ▸ | BTK | Q06187 | 9/20 | 0.42 |
| ▸ | EGFR | P00533 | 3/20 | 0.42 |
| ▸ | CMKLR1 | Q99788 | 7/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4028868 | 0.84 | ESR1 (0.71) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4030596 | 0.82 | ESR1 (0.69) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4028632 | 0.80 | ESR1 (0.65) | ESR1BTKEGFR | |
| SCHEMBL4030883 | 0.80 | ESR1 (0.68) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4027946 | 0.80 | ESR1 (0.65) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4027938 | 0.80 | ESR1 (0.61) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4027904 | 0.79 | ESR1 (1.00) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4029342 | 0.78 | ESR1 (0.69) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4025780 | 0.78 | ESR1 (0.97) | ESR1BTKEGFRCMKLR1 | |
| SCHEMBL4028629 | 0.78 | ESR1 (0.65) | ESR1BTKEGFRCMKLR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1542976-B1 | SUBSTITUTED 4-(INDAZOL-3-YL)PHENOLS AS ESTROGEN RECEPTOR (ER) LIGANDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | WYETH CORP (US) | 2009-02-04 | — | — | EP | claimed |